143 related articles for article (PubMed ID: 11223075)
1. CD40 ligation for immunotherapy of solid tumours.
Todryk SM; Tutt AL; Green MH; Smallwood JA; Halanek N; Dalgleish AG; Glennie MJ
J Immunol Methods; 2001 Feb; 248(1-2):139-47. PubMed ID: 11223075
[TBL] [Abstract][Full Text] [Related]
2. Induction of CTL responses by simultaneous administration of liposomal peptide vaccine with anti-CD40 and anti-CTLA-4 mAb.
Ito D; Ogasawara K; Iwabuchi K; Inuyama Y; Onoé K
J Immunol; 2000 Feb; 164(3):1230-5. PubMed ID: 10640735
[TBL] [Abstract][Full Text] [Related]
3. Activation of dendritic cells that cross-present tumor-derived antigen licenses CD8+ CTL to cause tumor eradication.
van Mierlo GJ; Boonman ZF; Dumortier HM; den Boer AT; Fransen MF; Nouta J; van der Voort EI; Offringa R; Toes RE; Melief CJ
J Immunol; 2004 Dec; 173(11):6753-9. PubMed ID: 15557168
[TBL] [Abstract][Full Text] [Related]
4. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions.
Schoenberger SP; Toes RE; van der Voort EI; Offringa R; Melief CJ
Nature; 1998 Jun; 393(6684):480-3. PubMed ID: 9624005
[TBL] [Abstract][Full Text] [Related]
5. Agonistic antibody to CD40 boosts the antitumor activity of adoptively transferred T cells in vivo.
Liu C; Lewis CM; Lou Y; Xu C; Peng W; Yang Y; Gelbard AH; Lizée G; Zhou D; Overwijk WW; Hwu P
J Immunother; 2012 Apr; 35(3):276-82. PubMed ID: 22421945
[TBL] [Abstract][Full Text] [Related]
6. Lipopolysaccharide modulation of dendritic cells is insufficient to mature dendritic cells to generate CTLs from naive polyclonal CD8+ T cells in vitro, whereas CD40 ligation is essential.
Kelleher M; Beverley PC
J Immunol; 2001 Dec; 167(11):6247-55. PubMed ID: 11714787
[TBL] [Abstract][Full Text] [Related]
7. Disruption of CD154:CD40 blocks generation of allograft immunity without affecting APC activation.
Shepherd DM; Kerkvliet NI
J Immunol; 1999 Sep; 163(5):2470-7. PubMed ID: 10452982
[TBL] [Abstract][Full Text] [Related]
8. CD40 engagement enhances antigen-presenting langerhans cell priming of IFN-gamma-producing CD4+ and CD8+ T cells independently of IL-12.
Gorbachev AV; Fairchild RL
J Immunol; 2004 Aug; 173(4):2443-52. PubMed ID: 15294958
[TBL] [Abstract][Full Text] [Related]
9. Melanoma immunotherapy by targeted IL-2 depends on CD4(+) T-cell help mediated by CD40/CD40L interaction.
Lode HN; Xiang R; Pertl U; Förster E; Schoenberger SP; Gillies SD; Reisfeld RA
J Clin Invest; 2000 Jun; 105(11):1623-30. PubMed ID: 10841521
[TBL] [Abstract][Full Text] [Related]
10. Nonreplicating recombinant vaccinia virus expressing CD40 ligand enhances APC capacity to stimulate specific CD4+ and CD8+ T cell responses.
Feder-Mengus C; Schultz-Thater E; Oertli D; Marti WR; Heberer M; Spagnoli GC; Zajac P
Hum Gene Ther; 2005 Mar; 16(3):348-60. PubMed ID: 15812230
[TBL] [Abstract][Full Text] [Related]
11. OX40 ligand-transduced tumor cell vaccine synergizes with GM-CSF and requires CD40-Apc signaling to boost the host T cell antitumor response.
Gri G; Gallo E; Di Carlo E; Musiani P; Colombo MP
J Immunol; 2003 Jan; 170(1):99-106. PubMed ID: 12496388
[TBL] [Abstract][Full Text] [Related]
12. Help for cytotoxic-T-cell responses is mediated by CD40 signalling.
Bennett SR; Carbone FR; Karamalis F; Flavell RA; Miller JF; Heath WR
Nature; 1998 Jun; 393(6684):478-80. PubMed ID: 9624004
[TBL] [Abstract][Full Text] [Related]
13. The role of CD40 in peripheral T cell tolerance and immunity.
Diehl L; Den Boer AT; van der Voort EI; Melief CJ; Offringa R; Toes RE
J Mol Med (Berl); 2000; 78(7):363-71. PubMed ID: 11043379
[TBL] [Abstract][Full Text] [Related]
14. CD40 ligation activates murine macrophages via an IFN-gamma-dependent mechanism resulting in tumor cell destruction in vitro.
Buhtoiarov IN; Lum H; Berke G; Paulnock DM; Sondel PM; Rakhmilevich AL
J Immunol; 2005 May; 174(10):6013-22. PubMed ID: 15879094
[TBL] [Abstract][Full Text] [Related]
15. Anti-CD40 monoclonal antibody therapy in combination with irradiation results in a CD8 T-cell-dependent immunity to B-cell lymphoma.
Honeychurch J; Glennie MJ; Johnson PW; Illidge TM
Blood; 2003 Aug; 102(4):1449-57. PubMed ID: 12714523
[TBL] [Abstract][Full Text] [Related]
16. In vivo CD40-CD154 (CD40 ligand) interaction induces integrated HIV expression by APC in an HIV-1-transgenic mouse model.
Chougnet C; Freitag C; Schito M; Thomas EK; Sher A; Shearer GM
J Immunol; 2001 Mar; 166(5):3210-7. PubMed ID: 11207274
[TBL] [Abstract][Full Text] [Related]
17. CD40-ligated dendritic cells effectively expand melanoma-specific CD8+ CTLs and CD4+ IFN-gamma-producing T cells from tumor-infiltrating lymphocytes.
Terheyden P; Straten P; Bröcker EB; Kämpgen E; Becker JC
J Immunol; 2000 Jun; 164(12):6633-9. PubMed ID: 10843723
[TBL] [Abstract][Full Text] [Related]
18. CD4+ and CD8+ T cell priming for contact hypersensitivity occurs independently of CD40-CD154 interactions.
Gorbachev AV; Heeger PS; Fairchild RL
J Immunol; 2001 Feb; 166(4):2323-32. PubMed ID: 11160289
[TBL] [Abstract][Full Text] [Related]
19. TRANCE, a tumor necrosis factor family member critical for CD40 ligand-independent T helper cell activation.
Bachmann MF; Wong BR; Josien R; Steinman RM; Oxenius A; Choi Y
J Exp Med; 1999 Apr; 189(7):1025-31. PubMed ID: 10190893
[TBL] [Abstract][Full Text] [Related]
20. Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival.
Lu L; Li W; Fu F; Chambers FG; Qian S; Fung JJ; Thomson AW
Transplantation; 1997 Dec; 64(12):1808-15. PubMed ID: 9422424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
